LifeVantage to Announce Third Quarter Fiscal Year 2017 Results on May 10, 2017
April 26 2017 - 9:00AM
LifeVantage Corporation (Nasdaq:LFVN), announced today that it will
release financial results for its third quarter ended March 31,
2017, after the stock market closes on Wednesday, May 10, 2017. The
Company will hold an investor conference call at 2:30 p.m. Mountain
Daylight Time (4:30 p.m. Eastern Daylight Time) that same day.
Investors interested in participating in the live call can dial
(888) 600-4863 from the U.S. International callers can dial (913)
312-0380. A telephone replay will be available approximately two
hours after the call concludes and will be available through
Wednesday, May 17, 2017, by dialing (844) 512-2921 from the U.S.
and entering confirmation code 9166571, or (412) 317-6671 from
international locations, and entering confirmation code
9166571.
There also will be a simultaneous, live webcast available on the
Investor Relations section of the Company's web site at
http://investor.lifevantage.com/events.cfm. The webcast will be
archived for approximately 30 days.
About LifeVantage Corporation
LifeVantage Corporation (Nasdaq:LFVN), is a science-based direct
selling company dedicated to visionary science that looks to
transform health, wellness and anti-aging internally and externally
at the cellular level. The company is the maker of Protandim® Nrf2
and NRF1 Synergizers, its line of scientifically-validated dietary
supplements, the TrueScience® Anti-Aging Skin Care Regimen,
Petandim™ for dogs, the AXIO® energy product line and the PhysIQ™
Smart Weight Management System. LifeVantage was founded in 2003 and
is headquartered in Salt Lake City, Utah. www.lifevantage.com
Investor Relations Contacts:
Cindy England
Director of Investor Relations
(801) 432-9036
investor@lifevantage.com
-or-
Scott Van Winkle
Managing Director, ICR
(617) 956-6736
scott.vanwinkle@icrinc.com
Lifevantage (NASDAQ:LFVN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Lifevantage (NASDAQ:LFVN)
Historical Stock Chart
From Apr 2023 to Apr 2024